Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia C Sanz, M Nomdedeu, M Belkaid, I Martinez, B Nomdedeu, A Pereira Transfusion 53 (4), 710-715, 2013 | 135 | 2013 |
Platelet‐specific antibodies in HLA‐immunized patients receiving chronic platelet support C Sanz, C Freire, I Alcorta, A Ordinas, A Pereira Transfusion 41 (6), 762-765, 2001 | 82 | 2001 |
Platelet activation on hemodialysis: influence of dialysis membranes. A Cases, JC Reverter, G Escolar, C Sanz, J Lopez-Pedret, L Revert, ... Kidney International Supplement, 1993 | 78 | 1993 |
Population screening for hemochromatosis: a study in 5370 Spanish blood donors M Sánchez, M Villa, M Ingelmo, C Sanz, M Bruguera, C Ascaso, R Oliva Journal of hepatology 38 (6), 745-750, 2003 | 74 | 2003 |
A model of the health and economic impact of posttransfusion hepatitis C: application to cost‐effectiveness analysis of further expansion of HCV screening protocols A Pereira, C Sanz Transfusion 40 (10), 1182-1191, 2000 | 58 | 2000 |
Platelet transfusions from D+ donors to D− patients: a 10‐year follow‐up study of 1014 patients J Cid, G Carbassé, A Pereira, C Sanz, R Mazzara, G Escolar, M Lozano Transfusion 51 (6), 1163-1169, 2011 | 57 | 2011 |
Guidelines on haemovigilance of post-transfusional iron overload A Remacha, C Sanz, E Contreras, CD De Heredia, JR Grifols, M Lozano, ... Blood Transfusion 11 (1), 128, 2013 | 52 | 2013 |
Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support A Pereira, M Nomdedeu, JL Aguilar, M Belkaid, A Carrió, F Cobo, D Costa, ... American journal of hematology 86 (3), 245-250, 2011 | 40 | 2011 |
Functional consequences of transferrin receptor‐2 mutations causing hereditary hemochromatosis type 3 R Joshi, M Shvartsman, E Morán, S Lois, J Aranda, A Barqué, ... Molecular genetics & genomic medicine 3 (3), 221-232, 2015 | 35 | 2015 |
Do patient-related blood donors represent a threat to the safety of the blood supply? A Pereira, C Sanz, D Tàssies, B Ramírez haematologica 87 (4), 427-433, 2002 | 35 | 2002 |
Relative sensitivity of direct antiglobulin test, antibody's elution and flow cytometry in the serologic diagnosis of immune hemolytic transfusion reactions A Alvarez, S Rives, S Montoto, C Sanz, A Pereira Haematologica 85 (2), 186-188, 2000 | 22 | 2000 |
DDAVP enhances the ability of blood monocytes to form rosettes with activated platelets by increasing the expression of P‐selectin sialylated ligands on the monocyte surface A Pereira, M del Valle Onorato, C Sanz British journal of haematology 120 (5), 814-820, 2003 | 20 | 2003 |
An enzyme-linked immunosorbent assay applicable to screen blood donors for IgA deficiency C Sanz, C Freire, A Ordinas, A Pereira Haematologica 84 (10), 887-890, 1999 | 17 | 1999 |
PMCID: PMC3557483 Á Remacha, C Sanz, E Contreras, CD de Heredia, JR Grifols, M Lozano, ... Blood Transfus 11 (1), 128-139, 2013 | 12 | 2013 |
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV‐2 neutralizing antibodies in hospitalized patients with COVID‐19 C Sanz, M Nomdedeu, A Pereira, S Sauleda, R Alonso, M Bes, ... Transfusion, 2022 | 10 | 2022 |
Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils A Alvarez‐Larrán, J Petriz, A Martínez, C Sanz, A Pereira British journal of haematology 120 (1), 129-134, 2003 | 10 | 2003 |
Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection C Sanz, A Faúndez, A García, M Rodríguez, AC Jaramillo, A Pereira Medicina clinica, 2021 | 5 | 2021 |
Hemorrhage is a major cause of blood transfusion in COVID-19 patients C Sanz, A Faundez, AG Carulla, MR Aliberas, A Coromoto, A Pereira Blood 136, 21-22, 2020 | 2 | 2020 |
Perfil clínico y motivo de transfusión de sangre en pacientes infectados por SARS-CoV-2 C Sanz, A Faúndez, A García, M Rodríguez, AC Jaramillo, A Pereira Medicina Clinica, 0 | | |